Nutrition

Guest: Tina Aswani Omprakash

Wellness includes many different aspects, but what about mental health and the stressors of life that affect IBD patients? Joining Dr. Charles Turck to share key takeaways from a session at the 2021 Crohn’s and Colitis Congress called “Holistic View of IBD Diet Disparities and Well-Being” is Tina Aswani Omprakash, patient advocate and co-moderator of the session.

Host: Neilanjan Nandi, MD
Guest: Tiffany H. Taft, PsyD

Patients with an inflammatory bowel disorder, or IBD, often suffer from post-traumatic stress disorder, or PTSD. But how do the psychological impacts of PTSD impact our IBD patients? Dr. Neil Nandi is joined by Dr. Tiffany Taft, the Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University, to discuss IBD’s relationship with PTSD.

Host: Neilanjan Nandi, MD
Guest: Tiffany H. Taft, PsyD

Avoidant Restrictive Food Intake Disorder, AFRID, is a newly introduced eating disorder at the forefront of GI care. Stay tuned to hear Dr. Neil Nandi discuss the impact of ARFID on GI health with Dr. Tiffany Taft, the Director of Psychogastroenterology Research in the Division of Gastroenterology and Hepatology at Northwestern University.

Host: Neilanjan Nandi, MD
Guest: Maria T. Abreu, MD

Environmental factors can affect many different aspects of a patient’s heath, but how do these factors play a role in developing inflammatory bowel disorders, or IBD? Tune in to hear Dr. Neil Nandi and Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, discuss the role of environmental factors in patients at risk of developing IBD.

Host: Neilanjan Nandi, MD
Guest: Maria T. Abreu, MD

Diet is a common concern for many patients with inflammatory bowel disorders. How can we best guide our patients on the influence of diet? Dr. Neil Nandi is joined by Dr. Maria Abreu, the director of the Crohn’s and Colitis Center at the University of Miami, to discuss the impact of diet on ulcerative colitis.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Devika Umashanker, MD

Obesity is a worldwide phenomenon and linked to morbidity and mortality. How can we help our obese patients along their weight loss journey to ensure long-term success? Dr. Peter Buch is joined by Dr. Devika Umashanker, Obesity Medicine Director of the Department of Bariatric Surgery at Hartford HealthCare Medical Group, to assess strategies for helping your patients see positive long-term weight loss outcomes.

Host: Stacy Kahn, MD
Guest: Jessica Allegretti, MD, MPH

FMT, or fecal microbiota transplantation, could be the therapeutic solution for patients with Crohn’s disease or ulcerative colitis. But what exactly is this treatment, and how is it changing the treatment landscape for patients with inflammatory bowel disease? Dr. Stacy Kahn, from Boston Children’s Hospital, is joined by Dr. Jessica Allegretti, from Brigham & Women’s Hospital, to discuss this new treatment option for IBD patients.

Host: Jennifer Caudle, DO
Guest: Matthew Coates, MD, PhD

Pain management is an unmet need for patients with IBD, or inflammatory bowel disease. How can we help them manage this excruciating symptom safely and effectively? Dr. Matthew Coates, a physician scientist at Penn State Health Gastroenterology, joins Dr. Jennifer Caudle to identify what causes chronic pain and how we can best serve our patients.

Host: Shira Johnson, MD
Guest: Arun Swaminath, MD

Recent studies have shown that smoking cannabis can improve some of the debilitating symptoms of inflammatory bowel disease, but the overall results are still inconclusive. Based on our current understanding, what is the impact of medical cannabis on IBD? Shira Johnson and Dr. Arun Swaminath, a practicing gastroenterologist at Northwell Health and Director of the Inflammatory Bowel Diseases Program at Lenox Hill Hospital, discuss the research of using cannabis to treat IBD.

Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD

The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe all winter long? Tune in to hear our Diabetes Discourse hosts Drs. Carol Wysham, John Buse, and John Anderson discuss strategies to effectively manage patients with diabetes during these winter months.

Published December X, 2020

Host: Kathy King, RDN
Guest: Megan Pesch, M.D.

Countless children across the nation are picky eaters, and families are on the lookout for effective solutions. With that in mind, Dr. Megan Pesch joins Kathy King to discuss her recent study on picky eaters and her insights on this common dilemma.

Guest: James Lindsay PhD, BM BCh, FRCP

Nutrition plays an important role in inflammatory bowel disease, but it’s important to instill in patients the understanding that even though a healthy diet can help reduce symptoms, it doesn’t mean that the disease itself has improved. Here to share how he talks about nutrition with his patients and other key management strategies like the low FODMAP diet is Dr. James Lindsay, Professor of Inflammatory Bowel Disease at Barts Health in London.

Published August 27, 2020

Host: Stacy Kahn, MD

Inflammatory bowel disease in pediatric patients is not as uncommon as you may think. Dr. Stacy Kahn, Assistant Professor of Pediatrics at Boston Children’s Hospital, shares her experience with healthy diet plans, preparing families for transition, and more.

Published August 7, 2020

Host: Kathy King, RDN
Guest: Teresa Pangan, PhD, RDN

Joining Kathy King to discuss the possible benefits and precautions of using supplemental doses of vitamin D to help fight COVID-19 is Dr. Teresa Pangan, a registered dietitian, health counselor, and keynote speaker.

Host: Abdullah Abdussalam, MD

Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s

Diana M Negoescu, Eva A Enns, PhD, Brooke Swanhorst, Bonnie Baumgartner, James P Campbell, Mark T Osterman, MD, Konstantinos Papamichael, PhD, Adam S Cheifetz, MD, Byron P Vaughn, MD

Background: Therapeutic drug monitoring (TDM) is increasingly performed for Infliximab (IFX) in patients with Crohn's disease (CD). Reactive TDM is a cost-effective strategy to empiric IFX dose escalation. The cost-effectiveness of proactive TDM is unknown. The aim of this study is to assess the cost-effectiveness of proactive vs reactive TDM in a simulated population of CD patients on IFX.

Methods: We developed a stochastic simulation model of CD patients on IFX and evaluated the expected health costs and outcomes of a proactive TDM strategy compared with a reactive strategy. The proactive strategy measured IFX concentration and antibody status every 6 months, or at the time of a flare, and dosed IFX to a therapeutic window. The reactive strategy only did so at the time of a flare.

<strong …

Host: Matt Birnholz, MD
Guest: James D. Lewis, MD, MSCE

The recipe for a healthy gut involves much more than just prescribing medications and diet restrictions. Treating the whole patient by identifying malnourishment, dermatologic conditions, and psychosocial needs can help ensure that IBD doesn’t have any negative impacts beyond the gut. Join Dr. Matt Birnholz as he digests the highlights from the 2020 Crohn's and Colitis Congress session "IBD: Beyond the Gut" with guest Dr. James Lewis.

Host: Joshua Sharfstein, MD
Host: Stephanie Desmon
Guest: Roni Neff

Bare shelves in grocery stores feed pandemic anxiety but Roni Neff, an expert on food systems and public health at the Johns Hopkins Center for a Livable Future, says this is not the biggest concern. Neff talks to Stephanie Desmon about how our robust food industry depends largely upon keeping its workers safe and well, how a pandemic completely shifts the model of emergency food access, and what’s being done to address these unique challenges to ensure everyone is fed.

Published April 16, 2020

Host: Linda Bernstein, Pharm.D.

Allergic reactions to peanut are unpredictable in occurrence and in how they present, with some individuals experiencing severe reactions from even trace amounts. Fortunately, there’s now an FDA-approved treatment option available that—when used in conjunction with peanut avoidance—can help reduce the risk of these allergic reactions in children with peanut allergy, as pharmacist Dr. Linda Bernstein explains.

Host: Maurice Pickard, MD
Guest: Christy Harrison, MPH, RD, CDN

Fad diets are extremely popular and widely used when it comes to losing weight, yet there’s often no scientific evidence to support them. That’s why Christy Harrison, author of Anti-Diet: Reclaim Your Time, Money, Well-Being, and Happiness Through INTUITIVE EATING, is here to dive into diet culture, fads, and intuitive eating.

Host: Andrew Wilner, MD, FACP, FAAN
Guest: Colin Zhu, DO

Everyone loves eating, but what if we told you that eating specific foods could be used as a primary treatment? Dr. Andrew Wilner is joined by Dr. Colin Zhu to discuss the combination of culinary arts and the science of medicine along with how he educates the healthcare community about culinary medicine.